India Molecular Diagnostics Market Size & Outlook

The molecular diagnostics market in India is expected to reach a projected revenue of US$ 671.8 million by 2030. A compound annual growth rate of -22.1% is expected of India molecular diagnostics market from 2024 to 2030.
Revenue, 2023 (US$M)
$3,850.7
Forecast, 2030 (US$M)
$671.8
CAGR, 2024 - 2030
-22.1%
Report Coverage
India

India molecular diagnostics market, 2018-2030 (US$M)

India

India molecular diagnostics market highlights

  • The India molecular diagnostics market generated a revenue of USD 3,850.7 million in 2023 and is expected to reach USD 671.8 million by 2030.
  • The India market is expected to grow at a CAGR of -22.1% from 2024 to 2030.
  • In terms of segment, outpatient facilities was the largest revenue generating end use in 2023.
  • Home Care is the most lucrative end use segment registering the fastest growth during the forecast period.


Molecular diagnostics market data book summary

Market revenue in 2023USD 3,850.7 million
Market revenue in 2030USD 671.8 million
Growth rate-22.1% (CAGR from 2023 to 2030)
Largest segmentOutpatient facilities
Fastest growing segmentHome Care
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationHospitals, Outpatient Facilities, Home Care
Key market players worldwideBecton Dickinson & Co, BioMerieux SA, Bio-Rad Laboratories Inc, Abbott Laboratories, Agilent Technologies Inc, Danaher Corp, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Roche Holding AG, Siemens Healthineers AG ADR, Sysmex Corp


Other key industry trends

  • In terms of revenue, India accounted for 7.9% of the global molecular diagnostics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,256.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Molecular Diagnostics Market Companies

Name Profile # Employees HQ Website

India molecular diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular diagnostics market will help companies and investors design strategic landscapes.


Outpatient facilities was the largest segment with a revenue share of 47.31% in 2023. Horizon Databook has segmented the India molecular diagnostics market based on hospitals, outpatient facilities, home care covering the revenue growth of each sub-segment from 2018 to 2030.


India’s market is a different scenario compared to the other countries in the Asia Pacific, such as China and Japan, owing to relaxed regulatory guidelines and the import of most equipment & materials from other countries. Its market is expected to grow significantly due to increased investments by private and foreign entities, which can help provide effective tests at lower costs. 

This can further improve the scope of the protein purification market in India. The well-distributed network of clinical laboratories and hospitals in India leads to faster adoption of protein purification techniques. Another factor expected to boost the molecular diagnostics market in India is the rising number of SARS-CoV-2 cases in the second wave. 

However, only 40% of these tests are PCR-based. Hence, the need for more cost-effective and faster PCR tests increased. The Indian Council of Medical Research (ICMR) allows private laboratories, such as Metropolis Labs, Reliance Life Sciences, Dr. LAL, SRL, and Thyrocare, to conduct testing for coronavirus.

Reasons to subscribe to India molecular diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of India molecular diagnostics market databook

  • Our clientele includes a mix of molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into India molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

India molecular diagnostics market size, by end use, 2018-2030 (US$M)

India Molecular Diagnostics Market Outlook Share, 2023 & 2030 (US$M)

India molecular diagnostics market size, by end use, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more